Screening of chronic diseases
Sensovann provides technology solutions encompassing recognition of disease-specific biomarkers targeted in body fluids and user-friendly, safe analysis of biomarker data.
Screening chronic disease from non-invasive fluids
Sensovann team is devoted to R&D of biological microsystems for early detection and/or monitoring chronic diseases, including but not limited to Chronic Obstructive Pulmonary Disease, Heart Failure, Cancer, etc. The technology routes target disease-specific molecules present in body fluids and whose variations in concentration are indicative of disease diagnostics or status of diagnosed disease. Sensovann´s focus is to provide point-of-care (POC) solutions by electro-optical and electrochemical assays for the sensitive detection of clinically important biomarkers. POCs are accompanied to a machining learning algorithms run in a smartphone APP for precise analysis and user-friendly display of results. The company´s strategy is oriented to generation of IPR and formal certification of its devices. Our target customers are leading healthcare industries, hospitals and municipal primary care.